These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 6431428)
1. Comparison of factor VIII and prothrombin complex concentrates in the treatment of inhibitor patients. Prentice CR Prog Clin Biol Res; 1984; 150():197-206. PubMed ID: 6431428 [No Abstract] [Full Text] [Related]
2. Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM N Engl J Med; 1980 Aug; 303(8):421-5. PubMed ID: 6771653 [TBL] [Abstract][Full Text] [Related]
3. Treatment of inhibitor patients with activated prothrombin complex concentrates. Penner JA Prog Clin Biol Res; 1984; 150():291-308. PubMed ID: 6431434 [TBL] [Abstract][Full Text] [Related]
4. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor]. Klukowska A; Zieleniewska B Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036 [TBL] [Abstract][Full Text] [Related]
10. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial. Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990 [TBL] [Abstract][Full Text] [Related]
11. New alternatives and strategies in the treatment of inhibitors. Hoyer LW Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440 [TBL] [Abstract][Full Text] [Related]
12. Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies. Teitel JM; Sholzberg M Blood Rev; 2013 Mar; 27(2):103-9. PubMed ID: 23452718 [TBL] [Abstract][Full Text] [Related]
13. Prothrombin complex concentrates and inhibitors. A reappraisal. Kasper CK JAMA; 1984 Jan; 251(1):68-9. PubMed ID: 6418899 [No Abstract] [Full Text] [Related]
14. Porcine factor VIII: preparation and use in treatment of inhibitor patients. Kernoff PB Prog Clin Biol Res; 1984; 150():207-24. PubMed ID: 6431429 [No Abstract] [Full Text] [Related]
15. Inhibitors of factor VIII: detection and treatment. Brettler DB Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576 [TBL] [Abstract][Full Text] [Related]
16. Increased fibrinopeptide A after prothrombin complex concentrates. ViganĂ³ S; Cattaneo M; Gervasoni W; Mannucci PM Thromb Haemost; 1980 Oct; 44(2):72-5. PubMed ID: 6779400 [TBL] [Abstract][Full Text] [Related]
17. [Hemophilia A with inhibitor]. Takahashi I Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):498-501. PubMed ID: 9833554 [No Abstract] [Full Text] [Related]
18. Recombinant blood clotting proteins for hemophilia therapy. Limentani SA; Roth DA; Furie BC; Furie B Semin Thromb Hemost; 1993; 19(1):62-72. PubMed ID: 8456325 [No Abstract] [Full Text] [Related]
19. The response to factor VIII infusion in inhibitor patients. Allain JP; Verroust F Prog Clin Biol Res; 1984; 150():99-108. PubMed ID: 6431445 [No Abstract] [Full Text] [Related]
20. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A. Sullivan DW; Purdy LJ; Billingham M; Glader BE Pediatrics; 1984 Aug; 74(2):279-81. PubMed ID: 6431390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]